| Cellular and Molecular Biology 1: DNA Methylation and Silencing |
| Cellular and Molecular Biology 2: DNA Methylation, Markers and Methylator Phenotype |
| Cellular and Molecular Biology 3: EGFR Family Signaling |
| Cellular and Molecular Biology 4: Gene Expression I |
| Cellular and Molecular Biology 5: Gene Expression 2 |
| Cellular and Molecular Biology 6: Genomics 1: DNA Profiling and Integrated Approaches |
| Cellular and Molecular Biology 7: Receptor Trafficking, Processing, and Crosstalk 1 |
| Cellular and Molecular Biology 8: Screening and Analysis of Genetic and Epigenetic Mutations |
| Tumor Biology 1: Angiogenesis Inhibitors 1 |
| Tumor Biology 2: Animal Models of Human Cancers 1: Hematopoietic, Metastasis, etc. |
| Tumor Biology 3: Chemokines and Other Soluble Mediators of Cancer Initiation, Progression, and Metastasis |
| Tumor Biology 4: Stem Cells in Cancer 1 |
| Carcinogenesis 1: Molecular Carcinogenesis |
| Carcinogenesis 2: Molecular Signaling Pathways in Cancer |
| Clinical Research 1: Clinical Research 1: Gastrointestinal Malignancy |
| Clinical Research 2: Endocrine Related Cancers |
| Epidemiology 1: Genes and Biomarkers in Tobacco-related Cancer |
| Experimental and Molecular Therapeutics 1: Antimicrotubule Agents |
| Experimental and Molecular Therapeutics 2: Cytotoxics and DNA Damage and Repair |
| Experimental and Molecular Therapeutics 3: DNA Interactive Agents |
| Experimental and Molecular Therapeutics 4: Preclinical Radiotherapeutics |
| Experimental and Molecular Therapeutics 5: The Role of Transporters in Drug Resistance |
| Immunology 1: Natural Killer Cells and Antibody-based Immune Function |
| Prevention Research 1: Behavioral and Social Science Research in Cancer Prevention and Detection |
| Prevention Research 2: Model Systems and Biomarkers 1 |
| Cellular and Molecular Biology 9: Cell Survival Mechanisms 1 |
| Cellular and Molecular Biology 10: Death Receptors 1 |
| Cellular and Molecular Biology 11: Death Receptors 2/Inhibitors of Apoptosis |
| Cellular and Molecular Biology 12: DNA Repair: Double-Stranded, Single-Stranded, Base Excision, and Nucleotide Excision |
| Cellular and Molecular Biology 13: Expression Profiling in Tumors and Model Systems |
| Cellular and Molecular Biology 14: Gene Expression Profiling |
| Cellular and Molecular Biology 15: Mechanisms of Transcription |
| Cellular and Molecular Biology 16: Molecular Markers in Diagnosis and Prognosis of Neoplastic Disease |
| Cellular and Molecular Biology 17: Signaling in Hormonally Regulated Tumors |
| Tumor Biology 5: Angiogenesis Inhibitors 2 |
| Tumor Biology 6: In Vivo Imaging 1 |
| Tumor Biology 7: Stem Cells in Cancer 2 |
| Tumor Biology 8: Tumor Angiogenesis and the Microenvironment 1 |
| Carcinogenesis 3: DNA Repair and Genomic Instability |
| Chemistry 1: Drug Delivery, Targeting and Radiotherapeutics |
| Chemistry 2: Drug Discovery 1: Screening, Synthesis, and Structure-Activity Relationships |
| Clinical Research 3: Clinical Research 2:Hematologic Malignancy/Melanoma/Sarcoma |
| Clinical Research 4: Preclinical Modeling of Emerging Immunotherapy Approaches |
| Epidemiology 3: Determinants of Survivorship |
| Experimental and Molecular Therapeutics 6: Growth Factors |
| Experimental and Molecular Therapeutics 7: Identification of Drug Resistance Mechanisms |
| Experimental and Molecular Therapeutics 8: Molecular Markers for Selection and Monitoring Therapy |
| Experimental and Molecular Therapeutics 9: Predicting Toxicity / Cellular Pharmacology |
| Experimental and Molecular Therapeutics 10: Targeted Therapeutics |
| Experimental and Molecular Therapeutics 11: Therapeutic Agents Targeting Signaling Components |
| Prevention Research 3: Model Systems and Biomarkers 2 |
| Cellular and Molecular Biology 18: Cell Death, Survival, and Senescence |
| Cellular and Molecular Biology 19: Oncogenic Mutations and Signaling Activation |
| Tumor Biology 9: Inflammation and Cancer |
| Carcinogenesis 4: Signaling and Carcinogenesis |
| Chemistry 3: Proteomic Analysis of Signaling Networks |
| Experimental and Molecular Therapeutics 12: Signal Transduction Inhibitors |
| Immunology 3: Tumor Antigens and Immune Mechanisms |
| Cellular and Molecular Biology 20: Cell Cycle 1 |
| Cellular and Molecular Biology 21: Computational Biology and Bioinformatics |
| Cellular and Molecular Biology 22: DNA Methylation and Imprinting |
| Cellular and Molecular Biology 23: DNA Methylation and Profiling |
| Cellular and Molecular Biology 24: Receptor Signaling |
| Cellular and Molecular Biology 25: Signaling and Tumor Microenvironment 1 |
| Cellular and Molecular Biology 26: Transcription Factor Function |
| Cellular and Molecular Biology 27: Transcription Factors |
| Tumor Biology 10: Angiogenesis Inhibitors 3 |
| Tumor Biology 11: Animal Models of Human Cancers 2: Breast and Reproductive Tissues |
| Tumor Biology 12: Cell Motility and Migration |
| Tumor Biology 13: Expression Profiling: Cancer Initiation and Progression |
| Tumor Biology 14: Tumor Angiogenesis and the Microenvironment 2 |
| Carcinogenesis 5: Environmental and Endogenous Carcinogens |
| Chemistry 4: Natural Products, Structural Biology, and Modeling |
| Clinical Research 5: Clinical Research 3: Solid Tumors |
| Clinical Research 6: New Targets and Methodologies for Immunotherapy |
| Epidemiology 4: Diet, Alcohol, Energy Balance, and Cancer Risk |
| Epidemiology 5: DNA Polymorphisms, Adducts, and Repair |
| Experimental and Molecular Therapeutics 13: Cell Cycle Components in Therapeutics |
| Experimental and Molecular Therapeutics 14: Gene and Vector-based Therapy 1 |
| Experimental and Molecular Therapeutics 15: Novel Mechanisms to Enhance Chemotherapy Efficacy |
| Experimental and Molecular Therapeutics 16: Novel Preclinical Combinations |
| Experimental and Molecular Therapeutics 17: Novel Therapeutic Targets |
| Experimental and Molecular Therapeutics 18: Signaling and Apoptosis |
| Immunology 4: Tumor Antigens |
| Prevention Research 4: Phytochemicals/Chemoprevention 1 |
| Cellular and Molecular Biology 28: Epigenetics, Drug Resistance, and Therapy |
| Cellular and Molecular Biology 29: Receptor Trafficking, Processing, and Crosstalk 2 |
| Tumor Biology 15: Radiation and DNA Breakage and Repair |
| Endocrinology 1: Endocrine Pathways to Targeted Therapy |
| Epidemiology 6: Susceptibility Genes |
| Experimental and Molecular Therapeutics 19: Novel Mechanisms of Drug Resistance |
| Prevention Research 5: Cox-2 and Lipids |
| Cellular and Molecular Biology 30: Cancer Epigenomes |
| Cellular and Molecular Biology 31: Regulation of Death Signaling |
| Tumor Biology 16: In Vivo Imaging 2 |
| Tumor Biology 17: Molecular and Cellular Determinants of Metastasis |
| Clinical Research 8: Novel Agents and New Technologies |
| Experimental and Molecular Therapeutics 20: Advances in Cancer Therapeutics |
| Experimental and Molecular Therapeutics 21: Molecular Therapeutics 1 |
| Cellular and Molecular Biology 32: Cell Death Regulators and Chemotherapy 1 |
| Cellular and Molecular Biology 33: Cell Migration, Proliferation, and Apoptosis |
| Cellular and Molecular Biology 34: Development and Drugs and Targets |
| Cellular and Molecular Biology 35: DNA Repair and Genomic Instability |
| Cellular and Molecular Biology 36: Gene Identification and Characterization 1 |
| Cellular and Molecular Biology 37: Genomics 2: DNA Profiling |
| Cellular and Molecular Biology 38: Posttranscriptional Control |
| Cellular and Molecular Biology 39: Proliferative Signaling and Cell Cycle Regulation |
| Cellular and Molecular Biology 40: TGF[bgr ] and Wnt Signaling Pathways |
| Cellular and Molecular Biology 41: Transcriptional and Posttranscriptional Control |
| Tumor Biology 18: Animal Models of Human Cancers 3: Central Nervous System and Imaging |
| Tumor Biology 19: Epithelial-Mesenchymal Transition, Cadherin, and Wnt |
| Tumor Biology 20: Tumor Angiogenesis and the Microenvironment 3 |
| Carcinogenesis 6: Animal and Cell Models of Cancer |
| Chemistry 5: Serum and Plasma Proteomics |
| Clinical Research 9: Early Clinical Studies of Emerging Immunotherapy Approaches |
| Clinical Research 10: Translational Endpoints in Single Agent and Combination Trials Using Novel Agents |
| Endocrinology 2: Nuclear Receptor Crosstalk and Non-genomic Signaling |
| Epidemiology 7: Perspectives of Susceptibility Genes in Families and Populations |
| Experimental and Molecular Therapeutics 22: Adenovector-based Therapy |
| Experimental and Molecular Therapeutics 23: Kinases and Oncogenesis |
| Experimental and Molecular Therapeutics 24: Molecular Mechanisms of Tumorigenesis, Identities of Novel Targets |
| Experimental and Molecular Therapeutics 25: Novel Approaches to Drug Delivery |
| Experimental and Molecular Therapeutics 26: Preclinical Disposition of Metabolism of New and Old Agents |
| Experimental and Molecular Therapeutics 27: Predicting Sensitivity and Resistance to Chemotherapy |
| Immunology 5: Dendritic Cells and Immune Regulation |
| Prevention Research 6: CoX-2 / Lipid Mediators / Other Agents |
| Cellular and Molecular Biology 42: Cell Cycle 2 |
| Cellular and Molecular Biology 43: DNA Methylation Markers and Profiling |
| Cellular and Molecular Biology 44: Gene Identification and Characterization 2 |
| Cellular and Molecular Biology 45: Mechanisms of Cell Migration and Invasion |
| Cellular and Molecular Biology 46: Nuclear Oncogenes and Tumor Suppressors |
| Cellular and Molecular Biology 47: p53 Responses to DNA Damage / Mismatch Repair Defects in Cancer |
| Cellular and Molecular Biology 48: p53: Regulation, Targets, and Function |
| Cellular and Molecular Biology 49: Translational Genomics |
| Tumor Biology 21: Cell-Cell and Cell-Extracellular Matrix Adhesion |
| Tumor Biology 22: Extracellular Matrix Proteins and Proteolysis in Cancer Progression |
| Tumor Biology 23: In Vivo Imaging 3 |
| Tumor Biology 24: Inflammation, Inflammatory Mediators, and Cancer |
| Tumor Biology 25: Molecular and Cellular Aspects of Tumor Invasion |
| Carcinogenesis 7: Inflammation, Reactive Oxygen Species, and Cancer |
| Chemistry 6: Tumor Proteome Analysis |
| Clinical Research 11: Breast Cancer |
| Clinical Research 12: Translational Endpoints: Techniques and Results |
| Endocrinology 3: Hormone Signaling in Breast Cancer |
| Epidemiology 8: Genes and Biomarkers in Prostate and Bladder Cancer |
| Epidemiology 9: Molecular Biomarkers of Cancer |
| Experimental and Molecular Therapeutics 28: Antibodies and Therapeutic Targets |
| Experimental and Molecular Therapeutics 29: Mechanisms of Drug Resistance |
| Experimental and Molecular Therapeutics 30: Novel Antitumor Agents 1 |
| Experimental and Molecular Therapeutics 31: Novel Antitumor Agents 2 |
| Experimental and Molecular Therapeutics 32: Targeting Multiple Levels in Molecular Therapeutics |
| Immunology 6: Cytokines and Immune Mechanisms |
| Prevention Research 7: Diet and Diet-related Factors |
| Prevention Research 8: Phytochemicals/Chemoprevention 2 |
| Cellular and Molecular Biology 50: Gene Regulation and Molecular Biology: Factors, DNA, and Chromatin |
| Cellular and Molecular Biology 51: Tumor Suppressors |
| Tumor Biology 26: Molecular and Cellular Aspects of Bone Metastasis |
| Tumor Biology 27: Stem Cells in Cancer 3 |
| Clinical Research 13: Emerging Themes: Enhancing Immunotherapy |
| Epidemiology 10: Diet and Cancer Risk |
| Experimental and Molecular Therapeutics 33: Gene and Vector-based Therapy 2 |
| Experimental and Molecular Therapeutics 34: Receptor Tyrosine Kinase Inhibitors |
| Cellular and Molecular Biology 52: Cell Death Regulators and Chemotherapy 2 |
| Cellular and Molecular Biology 53: Cell Survival Mechanisms 2: Bcl Family and Autophagy |
| Cellular and Molecular Biology 54: Cytosolic Signaling |
| Cellular and Molecular Biology 55: Extracellular Signaling |
| Cellular and Molecular Biology 56: Genomics 3: Functional Approaches and New Bench and Computational Tools |
| Cellular and Molecular Biology 57: Molecular Cytogenetic Studies: FISH and Array CGH |
| Cellular and Molecular Biology 58: Oncogenes |
| Cellular and Molecular Biology 59: PI3 Kinase / mTOR Signaling |
| Cellular and Molecular Biology 60: Transcription Factors in Signaling |
| Tumor Biology 28: Metastasis and Metastasis Suppressor Genes |
| Tumor Biology 29: Pediatric Cancer: Laboratory and Translational Science |
| Tumor Biology 30: Proteases: Protease Inhibitors and Cancer |
| Tumor Biology 31: Radiation Biology 1 |
| Tumor Biology 32: Radiation Biology 2 |
| Carcinogenesis 8: Viral Oncogenesis |
| Chemistry 7: Molecular and Cellular Proteomics |
| Clinical Research 14: Clinical Research 4: Head and Neck and Brain Cancer |
| Clinical Research 15: Clinical Research 5: Genitourinary Malignancy |
| Clinical Research 16: Clinical Research 6: Lung |
| Epidemiology 11: Environmental Factors, Biomarkers, and Prognostic Factors |
| Epidemiology 12: Susceptibility Genes and Diverse Pathways to Malignancy |
| Experimental and Molecular Therapeutics 35: Identification and Characterization of Novel Cellular Targets |
| Experimental and Molecular Therapeutics 36: Molecular Therapeutics 2 |
| Experimental and Molecular Therapeutics 37: Molecular Therapeutics 3 |
| Experimental and Molecular Therapeutics 38: Novel Antitumor Agents 3 |
| Experimental and Molecular Therapeutics 39: Novel Antitumor Agents 4 |
| Immunology 7: Immune Modulation in Cancer |
| Prevention Research 9: Phytochemicals/Chemoprevention 3 |
| Cellular and Molecular Biology 61: Signaling and Tumor Microenvironment 2 |
| Cellular and Molecular Biology 62: Signaling Downstream of Cell Surface Receptors |
| Tumor Biology 33: Genetically Engineered Animal Models for Human Cancers |
| Experimental and Molecular Therapeutics 40: Cytoplasmic Signaling Inhibitors |
| Experimental and Molecular Therapeutics 41: Emerging Themes: Enhancing Molecular Therapy |
| Immunology 8: Dendritic Cells and Inhibitory Pathways in Cancer |
| Prevention Research 10: Tea Catechins |
| Cellular and Molecular Biology 63: Cell Cycle 3 |
| Cellular and Molecular Biology 64: Cell Death Regulators and Chemotherapy 3 |
| Cellular and Molecular Biology 65: Cell Death Regulators and Chemotherapy 4 |
| Cellular and Molecular Biology 66: Cell Senescence Mechanisms |
| Cellular and Molecular Biology 67: Expression and Molecular Classification of Cancer |
| Cellular and Molecular Biology 68: Histone Modifications and Inhibitors |
| Cellular and Molecular Biology 69: Inhibitors of Signal Transduction in Cancer |
| Tumor Biology 34: Animal Models of Human Cancers 4: Lung, Gastrointestinal, and Angiogenesis |
| Tumor Biology 35: Emerging Molecules, Mechanisms, and Models |
| Tumor Biology 36: Markers of Metastasis |
| Tumor Biology 37: Radiation Biology 3 |
| Carcinogenesis 9 Carcinogenesis 9: Chemical Carcinogenesis |
| Carcinogenesis 9: Chemical Carcinogenesis |
| Chemistry 8: Carcinogenesis and DNA Repair |
| Clinical Research 17: Phase II and III Adult Clinical Trials 1 |
| Clinical Research 18: Prostate Cancer |
| Clinical Research 19: Radiation, Hyperthermia, Elderly Care, Study Design, Ethics, Quality of Life, and Race Effects |
| Endocrinology 4: Hormone Signaling in Prostate and Other Cancers |
| Epidemiology 13: Cancer in Children: Cancer Trends, Ethnicity, Epidemiology, and Screening |
| Epidemiology 14: Susceptibility Genes in Breast and Endometrial Cancer |
| Experimental and Molecular Therapeutics 42: Circumventing Drug Resistance |
| Experimental and Molecular Therapeutics 43: Conventional and Novel Therapeutic Approaches |
| Experimental and Molecular Therapeutics 44: Mechanisms of Action of Novel Therapeutics |
| Experimental and Molecular Therapeutics 45: Novel Targets for Therapy |
| Experimental and Molecular Therapeutics 46: Topoisomerase and Other Inhibitors |
| Immunology 9: Immunotherapy of Cancer |
| Prevention Research 11: Phytochemicals / Chemoprevention 4 |
| Cellular and Molecular Biology 70: Gene Regulation and Transcription Factors: Gene and RNA Networks |
| Cellular and Molecular Biology 71: Mechanisms of Cell Growth Control and DNA Repair |
| Tumor Biology 38: Molecular and Cellular Pathways in Pediatric Cancers |
| Carcinogenesis 10: Genomic Instability |
| Clinical Research 20: Phase II and III Adult Clinical Trials 2 |
| Epidemiology 15: Biomarkers of DNA Damage and Repair, Exposure, and Phenotype |
| Experimental and Molecular Therapeutics 47: Nuclear Interacting Agents |
| Cellular and Molecular Biology 72: Molecular Genetics: Markers and Genes |
| Cellular and Molecular Biology 73: Translational Genomics |
| Tumor Biology 39: Tumor Angiogenesis and Antiangiogenic Therapeutics |
| Chemistry 9: Drug Discovery 2 |
| Clinical Research 21: Prognostic and Predictive Factors |
| Experimental and Molecular Therapeutics 48: Oxygenation, In Vivo Measurement, and Radiation |
| Prevention Research 12: Prevention: Translational Studies |
| Forum: Successful Interventions to Recruit Minorities to Cancer Trials |
| Lecture: Ninth Annual Pezcoller Foundation-AACR International Award for Cancer Research |
| Plenary Session: Looking into the Future of Cancer Therapy |
| Special Session: New Drugs on the Horizon |
| Symposium: Interventions to Address Cancer Disparities |
| Symposium: Noncoding RNAs in Cancer |
| Symposium: Prenatal Exposure and Childhood Cancer |
| Symposium: Advances in Immunotherapy |
| Symposium: Comparative and Functional Proteomics |
| Symposium: DNA Damage Responses and Cell Cycle Checkpoints |
| Symposium: Stem Cells and Organogenesis |
| Symposium: Cancer Chromatin Connections |
| Symposium: Determinants of Cancer Disparities in Relation to Diagnosis, Treatment, and Outcome |
| Symposium: EGFR Mutations: From Altered Signaling to Drug |
| Symposium: Therapeutic Aspects of Angiogenesis |
| Symposium: Tumor Cell Survival: Strategies for Selective Killing of Malignant Cells |
| Symposium: Modeling Abnormal Proliferation in Model Organisms |
| Symposium: S Phase in Cancer Cells |
| Symposium: Tumor Microenvironment |
| Symposium: Integrin Signaling and Cancer |
| Symposium: Notch, Hedgehog, and Wnt Signaling Pathways in Cancer |
| Symposium: Testing the Cruciferous Vegetable-Cancer Relationship: From Basic Science to Observational Studies and Back |
| Symposium: Nanotechnology for Cancer Detection and Treatment |
| Symposium: Systems Biology of Cancer: From Mathematical Models to Biology |
| Symposium: Cancer Prevention in the Developing World |
| Symposium: Global siRNA Strategies for Gene Discovery |
| Symposium: Drug Targets in the MAPK Pathway |
